TXRH | ||
---|---|---|
OUTLOOK RATING 1..100 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | |
PROFIT vs RISK RATING 1..100 | 11 | |
SMR RATING 1..100 | 29 | |
PRICE GROWTH RATING 1..100 | 55 | |
P/E GROWTH RATING 1..100 | 75 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ACSI | TXRH | |
---|---|---|
RSI ODDS (%) | 2 days ago70% | N/A |
Stochastic ODDS (%) | 2 days ago84% | 2 days ago73% |
Momentum ODDS (%) | 2 days ago64% | 2 days ago58% |
MACD ODDS (%) | 2 days ago65% | N/A |
TrendWeek ODDS (%) | 2 days ago80% | 2 days ago57% |
TrendMonth ODDS (%) | 2 days ago78% | 2 days ago60% |
Advances ODDS (%) | N/A | 10 days ago70% |
Declines ODDS (%) | 8 days ago70% | 7 days ago52% |
BollingerBands ODDS (%) | N/A | 2 days ago72% |
Aroon ODDS (%) | 2 days ago74% | 2 days ago45% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AFPAX | 4.21 | 0.02 | +0.48% |
DSS AmericaFirst Income A | |||
ALCZX | 22.82 | 0.05 | +0.22% |
Alger International Opportunities Z | |||
CLCRX | 23.53 | 0.04 | +0.17% |
Columbia Select Large Cap Equity Inst2 | |||
NQVRX | 58.70 | -0.22 | -0.37% |
Nuveen Multi Cap Value I | |||
SHSAX | 56.53 | -0.28 | -0.49% |
BlackRock Health Sciences Opps Inv A |
A.I.dvisor indicates that over the last year, ACSI has been loosely correlated with PRU. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ACSI jumps, then PRU could also see price increases.
Ticker / NAME | Correlation To ACSI | 1D Price Change % | ||
---|---|---|---|---|
ACSI | 100% | N/A | ||
PRU - ACSI | 58% Loosely correlated | -1.12% | ||
RF - ACSI | 55% Loosely correlated | +0.15% | ||
META - ACSI | 52% Loosely correlated | +1.23% | ||
TXRH - ACSI | 48% Loosely correlated | -0.58% | ||
PINS - ACSI | 43% Loosely correlated | +2.40% | ||
More |